| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/26/2001 | WO2000003244A3 Immortalized human keratinocyte cell line |
| 04/26/2001 | US20010000521 Biological activity inhibiting topoisomerase I and/or topoisomerase II; antitumor agents, viricides |
| 04/26/2001 | US20010000513 Treatment of multiple sclerosis, atherosclerotic plaque rupture, aortic aneurism, heart failure, restenosis, periodontal disease, corneal ulceration, treatment of burns, decubital ulcers, wound healing, cancer, inflammation |
| 04/26/2001 | DE19951072A1 New cell constructs from activated T-cells of patients useful as a medicament |
| 04/26/2001 | DE19950933A1 Use of St. John's wort constituents for photodynamic diagnosis and/or therapy of mouth and malignant brain disorders |
| 04/26/2001 | DE19950898A1 New heteroaryl substituted fluoroalkyl-benzoylguanidine derivatives useful for treatment of e.g. ischemias, cardiac infarction, angina, shock, atherosclerosis, cancer and metabolic disorders |
| 04/26/2001 | DE19950647A1 Benzopyranoimidazolone and benzothiopyranoimidazolone derivatives as phosphodiesterase-VII inhibitors useful for treatment of e.g. asthma, psoriasis, osteoporosis, cachexia, sepsis, tumors and AIDS |
| 04/26/2001 | DE19949594A1 Rekombinante attenuierte Listerien zur Immuntherapie Recombinant attenuated Listeria for immunotherapy |
| 04/26/2001 | CA2388700A1 Conjugates useful in the treatment of prostate cancer |
| 04/26/2001 | CA2388503A1 Novel bicyclic cannabinoid agonists for the cannabinoid receptor |
| 04/26/2001 | CA2388497A1 Method of producing differentiated progenitor cells by culturing morula or inner cell mass cells |
| 04/26/2001 | CA2388450A1 Tadg-15: an extracellular serine protease overexpressed in carcinomas |
| 04/26/2001 | CA2388427A1 Methods for improving secondary metabolite production in fungi |
| 04/26/2001 | CA2387925A1 Magnetic targeted carrier composed of iron and porous materials for the targeted delivery of biologically active agents |
| 04/26/2001 | CA2387892A1 Pyrazole derivatives as cannabinoid receptor antagonists |
| 04/26/2001 | CA2387864A1 Nuclear matrix proteins, polynucleotide sequences encoding them, and their use |
| 04/26/2001 | CA2387855A1 Melanoma vaccine and methods of making and using same |
| 04/26/2001 | CA2387846A1 Retro-anandamides, high affinity and stability cannabinoid receptor ligands |
| 04/26/2001 | CA2387840A1 Tyrosine kinase inhibitors |
| 04/26/2001 | CA2387810A1 Novel human proteins and polynucleotides encoding the same |
| 04/26/2001 | CA2387767A1 Cobalamin conjugates useful as imaging and therapeutic agents |
| 04/26/2001 | CA2387757A1 Cobalamin conjugates useful as imaging agents and as antitumor agents |
| 04/26/2001 | CA2387558A1 Polyanhydrides with biologically active degradation products |
| 04/26/2001 | CA2387138A1 Cannabimimetic indole derivatives |
| 04/26/2001 | CA2387034A1 4,5-disubstituted-2-aminopyrimidines |
| 04/26/2001 | CA2386942A1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 04/26/2001 | CA2386922A1 Novel polypeptides and polynucleotides encoding same |
| 04/26/2001 | CA2386415A1 New lymphocytes, a process for preparing the same and their use in therapeutics |
| 04/26/2001 | CA2386143A1 Liposome formulation of 6,9-bis-[(2-aminoethyl)-amino]benzo[g]isoquinoline-5,10-dione dimaleate |
| 04/26/2001 | CA2384844A1 Novel process for making human papillomavirus virus-like particles with improved properties |
| 04/26/2001 | CA2384537A1 Modulation of angiogenesis |
| 04/26/2001 | CA2384264A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 04/25/2001 | EP1094109A2 Human G protein-coupled receptor, PFI-010 |
| 04/25/2001 | EP1094075A1 Human G-protein coupled receptor |
| 04/25/2001 | EP1094066A2 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
| 04/25/2001 | EP1093814A1 Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders |
| 04/25/2001 | EP1093811A1 Anti-tumor compositions containing taxan derivatives |
| 04/25/2001 | EP1093521A2 Human transferases |
| 04/25/2001 | EP1093465A2 Method for producing or enhancing a t-cell response against a target cell using a complex comprising an hla class i molecule and an attaching means |
| 04/25/2001 | EP1093460A1 Dolastatin 15 derivatives |
| 04/25/2001 | EP1093457A1 Cytokine receptor common gamma chain like |
| 04/25/2001 | EP1093456A2 Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents |
| 04/25/2001 | EP1093453A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 04/25/2001 | EP1093383A1 Drug delivery system comprising a homeobox peptide |
| 04/25/2001 | EP1093381A1 Antigenic peptides derived from telomerase |
| 04/25/2001 | EP1093362A1 Treatment of anti-estrogen resistant breast cancer using rxr modulators |
| 04/25/2001 | CN1292797A Cholenic acid amides and pharmaceutical compositions thereof |
| 04/25/2001 | CN1292789A 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 04/25/2001 | CN1292788A Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors |
| 04/25/2001 | CN1292782A Novel unsymmetrically substituted carboxylic acid derivatives, method for producing them, and their use as mixed ETA/ETB-receptor antagonists |
| 04/25/2001 | CN1292693A Indole-3-propionic acids, salts and esters thereof used as medicaments |
| 04/25/2001 | CN1292686A Delivery system to modulate immune response |
| 04/25/2001 | CN1292684A Emulsion preconcentrate containing cyclosporin or macrolide |
| 04/25/2001 | CN1292683A Compositions containing organic compounds |
| 04/25/2001 | CN1292420A New human NADH oxido-reductase composite I subunit and its code sequence |
| 04/25/2001 | CN1292419A New human III type ethanol dehydrogenase and its code sequence |
| 04/25/2001 | CN1292418A Heavy chain and light chain variable region gene of anti-C D 20 monoclonal antibody and its application |
| 04/25/2001 | CN1292266A Application of ammonium nilrate in pharmaceutical industry, food and health-care product |
| 04/25/2001 | CN1292263A New application of taxal anti-tumor medicine |
| 04/25/2001 | CN1064958C Method for preparation of taxol midbody |
| 04/25/2001 | CN1064956C Ortho-substd. benzoyl guanidine, its preparing method, use thereof and medicine contg. same |
| 04/25/2001 | CN1064955C Fluorine-containing benzoylguanidines |
| 04/25/2001 | CN1064836C Application of angelic lactone as biological reaction regulator to prepare antitumor medicine |
| 04/24/2001 | US6222036 Reacting 2-thio-4-dimethyoxymethyl-pyrimidine with acetic acid and catalytic amount of concetrated sulfuric acid to produce 2-thiopyrimidine aldehyde |
| 04/24/2001 | US6222026 Gcp |
| 04/24/2001 | US6222025 Process for the synthesis of 2′-O-substituted pyrimidines and oligomeric compounds therefrom |
| 04/24/2001 | US6222012 Isolated nonapeptides presented by HLA molecules, and uses thereof |
| 04/24/2001 | US6221959 Polynucleotide, polymer complex |
| 04/24/2001 | US6221958 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 04/24/2001 | US6221906 Anticancer agents |
| 04/24/2001 | US6221905 Salts of anionic complexes of RU(III), as antimetastatic and antineoplastic agents |
| 04/24/2001 | US6221893 Administration of histamine for therapeutic purposes |
| 04/24/2001 | US6221892 Heterocyclic topoisomerase poisons |
| 04/24/2001 | US6221891 Crystal form of N-(4-triflouromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/24/2001 | US6221876 190 kda multidrug resistance protein (mrp1); 1-amino-2-hydroxyindan-6-yl)isoxazolo(3, 4-c)-1,2-dihydro-3-methyl-6-chloroquinolin-2-one derivatives |
| 04/24/2001 | US6221873 Cyclin dependent kinase inhibitor |
| 04/24/2001 | US6221872 Debrominating a pyrrole; fusing the product with an amidine; condensing the product with a nucleophile; reducing and purifying |
| 04/24/2001 | US6221867 4,5-pyrazinoxindoles |
| 04/24/2001 | US6221850 For detecting and modulating levels of jun n-terminal kinases (jnk proteins), enzymes which are encoded by jnk genes. |
| 04/24/2001 | US6221849 Inhibiting tumor growth |
| 04/24/2001 | US6221848 In vivo administration to the subject of a polynucleotide encoding a protein that is transiently expressed in said subject; preventing esophagitis during treatment of lung cancer patients with ionizing radiation and/or chemotherapy |
| 04/24/2001 | US6221660 Amino acid sequence; recombinant production; drug screening using membrane preparations |
| 04/24/2001 | US6221627 cDNA clone HDPB130 that encodes a novel human 7-transmembrane receptor |
| 04/24/2001 | US6221593 Diagnosing tumors in cells which express tumor rejection antigen; incubate sample with oligonucleotides, detect hybridization, hybridization is indicative of tumors |
| 04/24/2001 | US6221577 Peptides which induce immune response and are useful in the diagnosis of urogenital tumors |
| 04/24/2001 | US6221351 The enhancement of antitumor immunity and in the treatment of cancer in a tumor-bearing host. |
| 04/24/2001 | US6221334 Polyaza macrocyclic ligands chelated to superparamagnetic or paramagnetic metals and coupled to folate-receptor binding ligands through the gamma carboxylate of folate |
| 04/24/2001 | CA2176620C Hepatic growth factor receptor is the met proto-oncogene |
| 04/24/2001 | CA2135277C Anti-receptor agents to the vitamin b12/transcobalamin ii receptor |
| 04/24/2001 | CA2070659C Antibody preparation |
| 04/19/2001 | WO2001027622A1 Crystallographic structure of the androgen receptor ligand binding domain |
| 04/19/2001 | WO2001027305A1 Process for producing, methods and compositions of cholesterol lowering agents from higher basidiomycetes mushrooms |
| 04/19/2001 | WO2001027300A1 Lentiviral vectors for the preparation of immunotherapeutical compositions |
| 04/19/2001 | WO2001027295A1 Recombinant attenuated listerias for immunotherapy |
| 04/19/2001 | WO2001027290A2 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 04/19/2001 | WO2001027281A1 Designing immunogens |
| 04/19/2001 | WO2001027268A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
| 04/19/2001 | WO2001027267A2 Genes differentially expressed in tr1 cells and their use in the manufacture of immunoregulatory compositions |
| 04/19/2001 | WO2001027265A1 Nucleic acid sequences of hyperplasia and tumours of the thyroid |
| 04/19/2001 | WO2001027245A2 Generation and characterization of a dendritic cell isolated from human peripheral blood mononuclear cells |